Prospective, Randomized Evaluation of Thrombectomy Prior to Percutaneous Intervention in Diseased Saphenous Vein Grafts and Thrombus-Containing Coronary Arteries

  • Gregg W. Stone
  • , David A. Cox
  • , Joseph Babb
  • , Dean Nukta
  • , Luc Bilodeau
  • , Louis Cannon
  • , Thomas D. Stuckey
  • , James Hermiller
  • , Eric A. Cohen
  • , Reginald Low
  • , Steven R. Bailey
  • , Alexandra J. Lansky
  • , Richard E. Kuntz

Research output: Contribution to journalArticlepeer-review

62 Scopus citations

Abstract

OBJECTIVES: We sought to determine whether routine thrombectomy prior to stent implantation in diseased saphenous vein grafts (SVGs) and thrombus-containing native coronary arteries would reduce peri-procedural myonecrosis and subsequently enhance event-free survival. BACKGROUND: Percutaneous coronary intervention in diseased SVGs and thrombotic native coronary arteries is complicated by a high rate of peri-procedural myocardial infarction (MI). Thrombectomy prior to intervention may enhance the safety of intervention and improve early and late outcomes in these high-risk patients. METHODS: At 60 centers in the U.S. and Canada, 797 patients with 839 diseased SVGs or thrombus-containing native coronary arteries were prospectively randomized to stent implantation with versus without prior thrombectomy with the X-SIZER device (ev3, Plymouth, Minnesota). RESULTS: Peri-procedural MI occurred in 15.8% of patients assigned to the X-SIZER device compared with 16. 6% of control patients (p = 0.77), although the rate of large MI (pre-specified as the development of new pathologic Q waves or creatine phosphokinase-MB isoenzyme elevation >8 x upper limits of normal) was reduced with X-SIZER device use from 9.6% to 5.5% (multivariate risk ratio 0.35 [95% confidence interval 0.18 to 0.66], p = 0.002). Major adverse cardiac events (cardiac death, MI, or repeat target vessel revascularization) occurred in 16.8% of X-SIZER patients versus 17.1% of control patients at 30 days (p = 0.92), and in 31.3% of X-SIZER patients versus 28.2% of control patients at 1 year (p = 0.35). CONCLUSIONS: Thrombectomy with the X-SIZER device prior to stent implantation in high-risk diseased SVGs and thrombus-containing native coronary arteries may reduce the extent, but not the occurrence, of myonecrosis. Early and late event-free survival, however, were not improved by routine thrombectomy with this device.

Original languageEnglish
Pages (from-to)2007-2013
Number of pages7
JournalJournal of the American College of Cardiology
Volume42
Issue number11
DOIs
StatePublished - 3 Dec 2003
Externally publishedYes

Fingerprint

Dive into the research topics of 'Prospective, Randomized Evaluation of Thrombectomy Prior to Percutaneous Intervention in Diseased Saphenous Vein Grafts and Thrombus-Containing Coronary Arteries'. Together they form a unique fingerprint.

Cite this